Profile
NURO specializes in neurotechnology and is the architect of the non-invasive NUOS product line. With NUOS, any human being, including highly incapacitated patients with akinetic mutism from a stroke, trauma or neurodegeneration can now communicate by brain; instantly and without any surgery of any kind. Over the past 7 years, the NURO team has worked with some of the key clinical leaders in the United States and has received IRB clearance from Northwestern University for research on human subjects, and US FDA clearance under expanded access as the only non-invasive treatment and communication technology available for late-stage neurodegeneration. We are seeking clinical and commercial partnerships with hospitals, rehabilitation clinics, speech language pathologists, occupational therapists and are interested in establishing regional to national commercial distribution agreements in the United States, Canada, the United Kingdom and the Europe.
Website
nuro.caContact
-
Francois Gand, Founder and CEOTel: +1 (226) 500-5320Email: francois@nuro.ca
Event details
Event contact
Participants
-
Brighter Sight, a Human-Systems Integration company, has been developing software for wearable devices for over 5… -
MIMOSA is transforming skin health assessments by seeing below the surface of the skin to predict tissue outcomes… -
NURO specializes in neurotechnology and is the architect of the non-invasive NUOS product line. With NUOS, any…